Bulletin
Investor Alert

Lipocine Inc.

NAS: LPCN

GO
/marketstate/country/us

After Hours

/zigman2/quotes/202742746/composite

$

0.84

Change

+0.02 +2.03%

Volume

Volume 817

Jun 28, 2022, 6:57 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202742746/composite

Today's close

$ 0.82

$ 0.82

Change

+0.0031 +0.38%

Day low

Day high

$0.82

$0.85

Open
Open: 0.84

52 week low

52 week high

$0.71

$1.89

Open

Market cap

$72.59M

Average volume

322,223

P/E ratio

N/A

Rev. per Employee

$1.24M

EPS

-0.01

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/lpcn

MarketWatch News on LPCN

  1. Lipocine shares plummet 35% after FDA fails to approve its testosterone replacement therapy

    7:03 a.m. May 9, 2018

    - Emma Court

  2. Lipocine downgraded to hold from buy at Canaccord

    11:22 a.m. Jan. 11, 2018

    - Tomi Kilgore

  3. Lipocine stock price target cut to $2 from $11 at Canaccord

    11:23 a.m. Jan. 11, 2018

    - Tomi Kilgore

  4. 6 stocks to watch

    3:38 p.m. Sept. 9, 2015

    - The Trading Deck

  5. 4 stocks to watch

    3:21 p.m. Sept. 2, 2015

    - The Trading Deck

  6. Bed Bath & Beyond surges on earnings

    5:39 p.m. Sept. 23, 2014

    - MarketWatch

Analyst Ratings

/news/nonmarketwatch/company/us/lpcn

Other News on LPCN

  1. 10-Q: LIPOCINE INC.

    8:06 a.m. May 9, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  2. MVIS, MRIN and CLVR among mid-day movers

    12:46 p.m. March 29, 2022

    - Seeking Alpha

  3. 10-K: LIPOCINE INC.

    9:04 a.m. March 9, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  4. 10-Q: LIPOCINE INC.

    9:03 a.m. Nov. 10, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  5. BGVF, VYNT and SNMP among pre market gainers

    8:38 a.m. Nov. 4, 2021

    - Seeking Alpha

  6. Warning: LPCN is at high risk of performing badly

    4:54 a.m. Oct. 27, 2021

    - Seeking Alpha

  7. AG, FRO and WATT among pre market gainers

    8:33 a.m. Oct. 19, 2021

    - Seeking Alpha

  8. FDA affirms class 1 NDA resubmission for Lipocine's Tlando

    8:35 a.m. Sept. 28, 2021

    - Seeking Alpha

  9. Lipocine discloses mid-stage data for NASH candidate

    8:29 a.m. Aug. 25, 2021

    - Seeking Alpha

  10. 10-Q: LIPOCINE INC.

    8:06 a.m. Aug. 5, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  11. Loading more headlines...
/news/pressrelease/company/us/lpcn

Press Releases on LPCN

  1. LIPOCINE GRANTED US PATENTS DIRECTED TO CNS AND LIVER PROGRAMS

    8:00 a.m. June 14, 2022

    - PR Newswire - PRF

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.